Hypertension and diabetes mellitus: a collision of two heavyweight non-communicable diseases

IF 0.6 Q4 ENDOCRINOLOGY & METABOLISM
S. Pillay
{"title":"Hypertension and diabetes mellitus: a collision of two heavyweight non-communicable diseases","authors":"S. Pillay","doi":"10.1080/16089677.2021.2002585","DOIUrl":null,"url":null,"abstract":"Introduction: Patients living with type 2 diabetes mellitus (PLWD) are at an increased risk of developing hypertension (HPT). The presence of HPT in PLWD (PLWDH) accelerates diabetes-related complications (DRC). Scarce data exist from South Africa on the impact of HPT in PLWD. Methods: Data werecaptured from Edendale Hospital diabetes clinic datasheets from January 1, 2019 to December 31, 2019 and analysed to determine differences in demographic, clinical and biochemical variables between PLWD and PLWDH. Results: Data from 822 PLWD were analysed, the majority having HPT (713,86.74%). The prevalence of HPT, resistant HPT (RHPT) and the number of antihypertensives used increased with age and diabetes duration. PLWDH had statistically poorer lipid control (LC), higher creatinine, waist circumference (WC), increased prevalence of sensory peripheral neuropathy, non-proliferative and proliferative retinopathy, cerebrovascular accidents, proteinuria and renal impairment. The significant majority of PLWDH were not meeting diabetes targets (glycaemic, lipid, BMI, WC). The bulk of PLWDH were on combination antihypertensive therapy (p < 0.001) and performed significantly better than monotherapy for glycaemia, LC, BMI and WC. Proteinuria and blood pressure (BP) improved significantly as the number of antihypertensives increased. One-fifth (151, 18.37%) of PLWDH had RHPT; this was more common in females (p < 0.001). PLWD with RHPT had a significantly higher LDL cholesterol, BMI, and urine protein–creatinine ratio (p < 0.001). Over one-quarter (29.87%) of the PLWD without HPT had a BP over 140/90mmHg. Conclusion: It was shown that HPT, RHPT and obesity are significant comorbidities in PLWD and increase the risk of DRC. The majority of PLWDH are not meeting targets, which places them at increased risk of DRC. BP, glycaemic and LC and proteinuria improved in those on combination antihypertensive therapy. A significant proportion of PLWD without HPT had elevated BP, and thus were potentially undiagnosed hypertensives needing intervention.","PeriodicalId":43919,"journal":{"name":"Journal of Endocrinology Metabolism and Diabetes of South Africa","volume":"1 1","pages":"57 - 69"},"PeriodicalIF":0.6000,"publicationDate":"2022-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Endocrinology Metabolism and Diabetes of South Africa","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/16089677.2021.2002585","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Patients living with type 2 diabetes mellitus (PLWD) are at an increased risk of developing hypertension (HPT). The presence of HPT in PLWD (PLWDH) accelerates diabetes-related complications (DRC). Scarce data exist from South Africa on the impact of HPT in PLWD. Methods: Data werecaptured from Edendale Hospital diabetes clinic datasheets from January 1, 2019 to December 31, 2019 and analysed to determine differences in demographic, clinical and biochemical variables between PLWD and PLWDH. Results: Data from 822 PLWD were analysed, the majority having HPT (713,86.74%). The prevalence of HPT, resistant HPT (RHPT) and the number of antihypertensives used increased with age and diabetes duration. PLWDH had statistically poorer lipid control (LC), higher creatinine, waist circumference (WC), increased prevalence of sensory peripheral neuropathy, non-proliferative and proliferative retinopathy, cerebrovascular accidents, proteinuria and renal impairment. The significant majority of PLWDH were not meeting diabetes targets (glycaemic, lipid, BMI, WC). The bulk of PLWDH were on combination antihypertensive therapy (p < 0.001) and performed significantly better than monotherapy for glycaemia, LC, BMI and WC. Proteinuria and blood pressure (BP) improved significantly as the number of antihypertensives increased. One-fifth (151, 18.37%) of PLWDH had RHPT; this was more common in females (p < 0.001). PLWD with RHPT had a significantly higher LDL cholesterol, BMI, and urine protein–creatinine ratio (p < 0.001). Over one-quarter (29.87%) of the PLWD without HPT had a BP over 140/90mmHg. Conclusion: It was shown that HPT, RHPT and obesity are significant comorbidities in PLWD and increase the risk of DRC. The majority of PLWDH are not meeting targets, which places them at increased risk of DRC. BP, glycaemic and LC and proteinuria improved in those on combination antihypertensive therapy. A significant proportion of PLWD without HPT had elevated BP, and thus were potentially undiagnosed hypertensives needing intervention.
高血压和糖尿病:两种重量级非传染性疾病的碰撞
2型糖尿病(PLWD)患者发生高血压(HPT)的风险增加。PLWD患者中HPT的存在加速了糖尿病相关并发症(DRC)。南非关于高压pt在PLWD中的影响的数据很少。方法:收集2019年1月1日至2019年12月31日Edendale医院糖尿病临床数据,分析PLWD和PLWDH在人口学、临床和生化指标上的差异。结果:对822例PLWD患者的资料进行了分析,其中大多数为HPT(713例,86.74%)。HPT的患病率、抗HPT (RHPT)和抗高血压药物的使用数量随着年龄和糖尿病病程的增加而增加。PLWDH患者的脂质控制(LC)较差,肌酐、腰围(WC)较高,感觉周围神经病变、非增殖性和增殖性视网膜病变、脑血管意外、蛋白尿和肾功能损害的患病率较高。绝大多数PLWDH未达到糖尿病指标(血糖、血脂、BMI、WC)。大部分PLWDH接受联合降压治疗(p < 0.001),在血糖、LC、BMI和WC方面的表现明显优于单药治疗。蛋白尿和血压(BP)随着抗高血压药物数量的增加而显著改善。五分之一(151,18.37%)的PLWDH患有RHPT;这在女性中更为常见(p < 0.001)。PLWD合并RHPT的LDL胆固醇、BMI和尿蛋白-肌酐比值显著升高(p < 0.001)。超过四分之一(29.87%)的无HPT PLWD患者血压超过140/90mmHg。结论:HPT、RHPT和肥胖是PLWD的重要合并症,并增加DRC的风险。大多数艾滋病毒感染者没有达到目标,这使他们面临更大的刚果民主共和国风险。联合抗高血压治疗组血压、血糖、LC和蛋白尿均有改善。没有HPT的PLWD患者中有很大一部分血压升高,因此可能是未确诊的高血压患者,需要干预。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
20.00%
发文量
15
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信